Individualized therapy of HHT driven by network analysis of metabolomic profiles

BACKGROUND: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disease with a varying range of phenotypes involving abnormal vasculature primarily manifested as arteriovenous malformations in various organs, including the nose, brain, liver, and lungs. The varied presentation and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamshidi, Neema, Miller, Franklin J, Mandel, Jess, Evans, Timothy, Kuo, Michael D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339509/
https://www.ncbi.nlm.nih.gov/pubmed/22185482
http://dx.doi.org/10.1186/1752-0509-5-200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339509/
https://www.ncbi.nlm.nih.gov/pubmed/22185482
http://dx.doi.org/10.1186/1752-0509-5-200

Ejemplares similares